BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 309 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,300,000 | -86.2% | 8,600 | -86.7% | 0.01% | -85.2% |
| Q2 2022 | $9,413,000 | -71.5% | 64,600 | -76.8% | 0.06% | -66.8% |
| Q1 2022 | $33,034,000 | -16.5% | 278,600 | -3.0% | 0.18% | -5.6% |
| Q4 2021 | $39,565,000 | +2.6% | 287,100 | +3.4% | 0.20% | -3.5% |
| Q3 2021 | $38,561,000 | +35.7% | 277,600 | -5.1% | 0.20% | +36.5% |
| Q2 2021 | $28,406,000 | +55.3% | 292,600 | +9.3% | 0.15% | +42.3% |
| Q1 2021 | $18,290,000 | -8.3% | 267,600 | +15.0% | 0.10% | -14.0% |
| Q4 2020 | $19,936,000 | +13.8% | 232,600 | -13.7% | 0.12% | -5.5% |
| Q3 2020 | $17,520,000 | -51.0% | 269,500 | -44.8% | 0.13% | -15.8% |
| Q2 2020 | $35,722,000 | +325.0% | 488,600 | +97.8% | 0.15% | -16.0% |
| Q1 2020 | $8,405,000 | -39.9% | 247,000 | -3.9% | 0.18% | -25.2% |
| Q4 2019 | $13,991,000 | +44.6% | 257,000 | +10.8% | 0.24% | +23.5% |
| Q3 2019 | $9,679,000 | +45.4% | 232,000 | +52.6% | 0.20% | +59.3% |
| Q2 2019 | $6,656,000 | – | 152,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |